# A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting

> **NCT00108095** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 701 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting
- Nausea and Vomiting, Postoperative

## Interventions

- **DRUG:** intravenous ondansetron

## Key facts

- **NCT ID:** NCT00108095
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 701 (ACTUAL)
- **Last updated:** 2017-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00108095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00108095, "A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00108095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*